Friday, October 22, 2021 8:56:05 AM
The Transaction is expected to close on October 22, 2021.https://www.otcmarkets.com/filing/html?id=15291335&guid=nzMwkpLZGSv1dth
On October 20, 2021, Nukkleus, Inc. (the “Company”) and the shareholders (the “Jacobi Shareholders”) of Jacobi Asset Management Holdings Limited (“Jacobi”) entered into a Purchase and Sale Agreement (the “Jacobi Agreement”) pursuant to which the Company agreed to acquire 5.0% of the issued and outstanding ordinary shares of Jacobi in consideration of 20,000,000 shares of common stock of the Company (the “Transaction”). The Transaction is expected to close on October 22, 2021.
All of the offers and sales of securities described above were made to accredited investors and the Company relied upon the exemptions contained in Section 4(a)(2) of the Securities Act of 1933, as amended, with regard to those sales. No advertising or general solicitation was employed in offering the securities. The offers and sales were made to a limited number of persons, each of whom was an accredited investor and transfer of the securities issued was restricted by the Company in accordance with the requirements of the Securities Act of 1933.
Recent NUKK News
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:36 PM
- Nukkleus Signs Term Sheet for Acquisition of Leading Cross Border Payments Firm Mercury Global • Business Wire • 02/14/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/26/2024 10:15:36 PM
- Nukkleus Appoints C. Derek Campbell to Board of Directors, Bolstering its Growing Footprint in Emerging Markets • Business Wire • 01/26/2024 06:13:00 PM
- Nukkleus Announces Collaboration between DRFQ and Tantel Group to Expand Footprint in Africa • Business Wire • 01/22/2024 12:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 02:21:33 PM
- Nukkleus Signs MOU to Substantially Increase Holdings in Jacobi Asset Management • Business Wire • 01/17/2024 01:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:16:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2024 10:21:43 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 01/02/2024 09:52:26 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM